What is the current share price of Akums Drugs and Pharmaceuticals Limited (AKUMS)?

As of the latest market update, Akums Drugs and Pharmaceuticals Limited (AKUMS) is trading at ₹701.95. The stock has moved 6.65% up in the recent session.

What is the technical sentiment for AKUMS stock?

Based on our proprietary technical analysis, the current signal for AKUMS is "STRONG_BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Akums Drugs and Pharmaceuticals Limited?

Akums Drugs and Pharmaceuticals Limited has seen a 52-week high of ₹707.4 and a 52-week low of ₹409.3. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Akums Drugs and Pharmaceuticals Limited belong to?

Akums Drugs and Pharmaceuticals Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of AKUMS?

Akums Drugs and Pharmaceuticals Limited (AKUMS) has a market capitalization of approximately ₹11.05K Cr. This classifies it as a small cap stock in the Indian market.

AKUMS

NSE

Akums Drugs and Pharmaceuticals Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹701.95

43.75 (6.65%)

High VOLATILITY

As on 10 Jul 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹11.05K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

43.1

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹409.3+71.5%

52W High₹707.4-0.8%

Current Price

₹701.95

Circuit Limits (10%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹631.76

Upper Circuit₹772.15

Reference Price

₹701.95

Investment Checklist

Composite score 60.13 (STRONG_BUY) with 84.0% confidence

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

RSI at 79.3 — overbought, pullback risk

3-day momentum: +8.0% — strong upward pressure

Unusual volume detected (2.4x average) — institutional activity likely

Technical Analysis

Analysis from 2026-07-11

Confidence

84%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

625.71

EMA50

585.77

EMA200

518.75

Price Action

UPTREND

BULLISH

Higher Highs7

Higher Lows7

Lower Highs2

Lower Lows2

Support & Resistance Levels

Resistance (Above)

No recent resistance detected

Support (Below)

₹635.00

₹592.00

₹567.00

₹554.14

₹544.50

Volume Analysis

TrendINCREASING

Change+41.80%

Unusual Volume

Yes (2.39x avg)

Stop Loss Levels

Fixed Risk

1% Risk₹694.93

3% Risk₹680.89

5% Risk₹666.85

7% Risk (Custom)

₹652.81

Technical Levels

1x ATR (Volatility)₹677.51

2x ATR (Swing)₹653.07

3x ATR (Trend)₹628.63

Immediate Support₹635.00

Moving Averages

EMA 9 (Short-term)₹649.92

EMA 20 (Medium-term)₹625.71

EMA 50 (Trend)₹585.77

EMA 200 (Long-term)₹518.75

Financials

Financial Analysis

Metric	Mar '25	Jun '25	Sep '25	Dec '25
Revenue	₹1,008.5 Cr	₹1,024 Cr	₹1,017.5 Cr	₹1,159.6 Cr
Net Profit	₹147.6 Cr	₹63.5 Cr	₹40.8 Cr	₹66.3 Cr
EPS	—	₹4.15	₹2.66	₹4.33
Operating Profit	₹115.5 Cr	₹150.8 Cr	₹123.4 Cr	₹163 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change	P/E Ratio	Market Cap
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,935.50	-0.17%	40.2	₹4.64L Cr large Cap
DIVISLAB	Divi's Laboratories Limited	₹6,836.00	+0.34%	70.7	₹1.81L Cr large Cap
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,901.50	+0.07%	77.6	₹1.66L Cr large Cap
CIPLA	Cipla Limited	₹1,439.40	-0.13%	30.1	₹1.16L Cr large Cap
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,150.80	-0.71%	22.8	₹1.16L Cr large Cap
LUPIN	Lupin Limited	₹2,496.30	-0.28%	21.3	₹1.14L Cr mid Cap
MANKIND	Mankind Pharma Limited	₹2,525.10	-0.27%	54.1	₹1.04L Cr mid Cap
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,244.30	-1.99%	25.1	₹1.04L Cr large Cap
AUROPHARMA	Aurobindo Pharma Limited	₹1,564.70	-1.43%	25.7	₹90.88K Cr mid Cap
LAURUSLABS	Laurus Labs Limited	₹1,537.80	+2.02%	93.4	₹83.02K Cr mid Cap
AKUMS	Akums Drugs and Pharmaceuticals Limited	₹701.95	+6.65%	43.1	₹11.05K Cr small Cap

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
03 Jul 2026	Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share	SPECIAL_DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
11 Jul 2026	Shareholders meeting
10 Jul 2026	Shareholders meeting
08 Jul 2026	Certificate under SEBI (Depositories and Participants) Regulations, 2018
04 Jul 2026	Action(s) taken or orders passed
25 Jun 2026	Trading Window

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
14 May 2026	Board Meeting Intimation	XBRL
14 May 2026	Dividend
14 May 2026	Financial Results
13 Feb 2026	Financial Results
13 Feb 2026	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 6 Qtrs)

Latest News

News for AKUMS

View All

Maharashtra FDA bars sale of two Cadila drugs over branding concerns

positive

ET Markets - Industry 2h ago

Maharashtra FDA bars sale of two Cadila drugs over branding concerns

Maharashtra FDA has seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore. The action was taken due to similar branding on different active ingredients. Officials barred sales of Aciloc 150 Plus and Aciloc 300 Plus medicines. This move aims to prevent medication errors and safeguard public health. Further investigation and legal action are currently underway.

AAREYDRUGSAKUMSMEDANTAHealthcare

Read full story

Sun Pharma secures relief in 'Pantocid' trademark dispute

positive

ET Markets - Industry 7d ago

Sun Pharma secures relief in 'Pantocid' trademark dispute

Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.

AAREYDRUGSABGSECAKUMSSPARCFinancial ServicesHealthcare

Read full story

Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox

positive

Google News - India Markets 29d ago

Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox

Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSEUpstox

AEGISLOGAKUMSCUPIDJGCHEMPARSJLOGISTICChemicalsFast Moving Consumer Goods

Read full story

AKUMS

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 6 Qtrs)

Latest News

News for AKUMS

Maharashtra FDA bars sale of two Cadila drugs over branding concerns

Sun Pharma secures relief in 'Pantocid' trademark dispute

Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox

Frequently Asked Questions

What is the current share price of Akums Drugs and Pharmaceuticals Limited (AKUMS)?

What is the technical sentiment for AKUMS stock?

What is the 52-week high and low for Akums Drugs and Pharmaceuticals Limited?

Which sector does Akums Drugs and Pharmaceuticals Limited belong to?

What is the market capitalization of AKUMS?